Inflammation linked to depression in women with diabetes, but biomarkers paint complex picture: Study Dr. Kamal Kant Kohli24 March 2026 9:00 PM ISTInflammation markers may signal depression in women with type 2 diabetes, but vary based on depression symptoms and measures, according to a new study...
Less-Frequent GLP-1 Injections May Maintain Weight Loss in Some Patients: Study Medha Baranwal24 March 2026 9:00 PM ISTUSA: A small study published in Obesity found that some patients using GLP-1 weight-loss medications were able to sustain their weight reduction and...
TRIUMPH Program Showcases Retatrutide’s Potency of 24 Percent Weight Loss: Study Finds Aashi verma24 March 2026 9:00 PM ISTThe TRIUMPH program’s innovative approach suggests that retatrutide could offer a clinical breakthrough in managing obesity-related morbidity by...
GLP-1 Drugs Improve Metabolic Outcomes in Cushing's Syndrome Without Hormonal Harm: Study Dr Riya Dave24 March 2026 8:45 AM ISTResearchers have discovered in a new study that among patients with Cushing's syndrome, treatment with GLP-1 drugs led to significant weight loss and...
Metformin Linked to Lower Esophageal Cancer Risk: JAMA Dr Riya Dave23 March 2026 8:45 PM ISTA Nordic case-control study published in JAMA Network Open has found that the use of metformin was associated with a reduced risk of developing...
Weight Loss Drugs in Early Pregnancy Linked to Premature Birth Risk in Diabetics: Study Dr. Kamal Kant Kohli23 March 2026 8:30 PM ISTWeight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just before or during early...
Liver Stiffness Measurement Predicts Mortality Risk in Type 2 Diabetes: JAMA Dr Riya Dave23 March 2026 10:30 AM ISTLiver stiffness measurement (LSM) is an effective noninvasive tool for detecting liver fibrosis and identifying increased risk of all-cause mortality...
Fracture Risk Assessment Tool May Guide Parathyroidectomy Decisions in Primary Hyperparathyroidism: JAMA Medha Baranwal22 March 2026 8:30 PM ISTUSA: A recent cohort study suggests that the Fracture Risk Assessment Tool can help identify patients with primary hyperparathyroidism (PHPT) who may...
USV Launches USEMA - DCGI-Approved Injectable Semaglutide for Type 2 Diabetes Dr. Bhumika Maikhuri21 March 2026 11:02 AM ISTUSV Private Limited, a leading name in diabetes care, has announced the launch of USEMA, its semaglutide injection, for the management of Type 2...
Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Deeksha Bhandari21 March 2026 9:00 AM ISTThe SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or equal to 27 with a comorbidity)...
Retatrutide Shows Strong Glycemic Control and Weight Loss in Phase 3 Trial Dr. Kamal Kant Kohli21 March 2026 8:45 AM ISTRetatrutide demonstrated promising results in its first late-stage trial for Type 2 Diabetes, reducing HbA1c levels by up to 2% and achieving an...
Vitamin D Supplementation May Improve Outcomes in COVID-19: Study Medha Baranwal20 March 2026 9:15 PM ISTChina: Supplementing vitamin D alongside standard treatment may reduce inflammatory markers, shorten the duration of illness, and contribute to...
